131 related articles for article (PubMed ID: 27662245)
1. MED28 Regulates Epithelial-Mesenchymal Transition Through NFκB in Human Breast Cancer Cells.
Huang CY; Hsieh NT; Li CI; Weng YT; Liu HS; Lee MF
J Cell Physiol; 2017 Jun; 232(6):1337-1345. PubMed ID: 27662245
[TBL] [Abstract][Full Text] [Related]
2. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
Lee MF; Hsieh NT; Huang CY; Li CI
J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
[TBL] [Abstract][Full Text] [Related]
3. MED28 regulates MEK1-dependent cellular migration in human breast cancer cells.
Huang CY; Chou YH; Hsieh NT; Chen HH; Lee MF
J Cell Physiol; 2012 Dec; 227(12):3820-7. PubMed ID: 22495818
[TBL] [Abstract][Full Text] [Related]
4. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
[TBL] [Abstract][Full Text] [Related]
5. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
[TBL] [Abstract][Full Text] [Related]
6. Bioactive Vitamin D Attenuates MED28-Mediated Cell Growth and Epithelial-Mesenchymal Transition in Human Colorectal Cancer Cells.
Huang CY; Weng YT; Hsieh NT; Li PC; Lee TY; Li CI; Liu HS; Lee MF
Biomed Res Int; 2022; 2022():2268818. PubMed ID: 36072467
[TBL] [Abstract][Full Text] [Related]
7. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
[TBL] [Abstract][Full Text] [Related]
9. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
10. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.
Li X; Kong X; Huo Q; Guo H; Yan S; Yuan C; Moran MS; Shao C; Yang Q
Cancer Sci; 2011 Jun; 102(6):1151-7. PubMed ID: 21371176
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition in breast epithelial cells treated with cadmium and the role of Snail.
Wei Z; Shan Z; Shaikh ZA
Toxicol Appl Pharmacol; 2018 Apr; 344():46-55. PubMed ID: 29501589
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells.
Lee MF; Pan MH; Chiou YS; Cheng AC; Huang H
J Agric Food Chem; 2011 Nov; 59(21):11853-61. PubMed ID: 21942447
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-Mesenchymal Transition in Paclitaxel-Resistant Ovarian Cancer Cells Is Downregulated by Luteolin.
Dia VP; Pangloli P
J Cell Physiol; 2017 Feb; 232(2):391-401. PubMed ID: 27198989
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits LPS-induced EMT through downregulation of NF-κB-Snail signaling in breast cancer cells.
Huang T; Chen Z; Fang L
Oncol Rep; 2013 Jan; 29(1):117-24. PubMed ID: 23076367
[TBL] [Abstract][Full Text] [Related]
15. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
16. Sef Regulates Epithelial-Mesenchymal Transition in Breast Cancer Cells.
He Q; Gong Y; Gower L; Yang X; Friesel RE
J Cell Biochem; 2016 Oct; 117(10):2346-56. PubMed ID: 26950413
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer.
Zhang JT; Jiang XH; Xie C; Cheng H; Da Dong J; Wang Y; Fok KL; Zhang XH; Sun TT; Tsang LL; Chen H; Sun XJ; Chung YW; Cai ZM; Jiang WG; Chan HC
Biochim Biophys Acta; 2013 Dec; 1833(12):2961-2969. PubMed ID: 23916755
[TBL] [Abstract][Full Text] [Related]
18. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
19. N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling.
Kim MJ; Lim J; Yang Y; Lee MS; Lim JS
Cancer Lett; 2014 Nov; 354(1):33-42. PubMed ID: 25153349
[TBL] [Abstract][Full Text] [Related]
20. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
